Trial Profile
A phase I trial of clofarabine in combination with high-dose etoposide and cyclophosphamide and autologous peripheral bloold stem cell transplantation for patients with high-risk or refractory non-Hodgkin's lymphoma.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2013
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary) ; Cyclophosphamide; Etoposide
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 30 Mar 2012 Actual patient number is 18 according to ClinicalTrials.gov.
- 30 Mar 2012 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 30 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.